NV
NVS
HealthcareNovartis AG
Drug Manufacturers - General
Total Trades
13
Unique Traders
3
Purchases / Sales
6/7
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Feb 13, 2026 |  Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $158.28 | $153.44 | -3.1% | -0.2% | |
Oct 31, 2025 |  Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $123.79 | $130.40 | +5.3% | +5.1% | |
Oct 30, 2025 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $122.61 | $130.40 | +6.4% | +5.8% | |
Oct 30, 2025 | Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $122.61 | $130.40 | +6.4% | +5.8% | |
Sep 25, 2025 | Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $118.62 | $126.51 | +6.7% | +3.7% | |
Sep 11, 2025 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $123.93 | $126.19 | +1.8% | +2.3% | |
Jul 22, 2025 | Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $116.83 | $126.82 | +8.6% | +7.5% | |
Jun 17, 2025 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $116.41 | $114.52 | -1.6% | -7.0% | |
Jun 11, 2025 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $118.07 | $121.02 | +2.5% | -1.5% | |
Jun 9, 2025 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $118.02 | $122.94 | +4.2% | -0.2% | |
Mar 24, 2025 |  George WhitesidesD | Stock | Sell | $100,001 - $250,000 | $107.81 | $106.88 | -0.9% | +5.9% |
Recent News
President Trump Says He Met With Novartis CEO On Wednesday
Benzinga-Invalid Date
Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock with Strong Fundamentals
ChartMill-Invalid Date
Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade)
SeekingAlpha-Invalid Date
Itchy Skin Conditions? Novartis' Pivotal Trial Success Shows Potential For Targeted Relief
Benzinga-Invalid Date
Novartis Says Topline Results From Its Phase 3 RemIND Trial Of Oral Remibrutinib In Chronic Inducible Urticaria Met The Primary Endpoint, Achieving Significantly Higher Complete Response Rates Versus Placebo At Week 121
Benzinga-Invalid Date